Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Fibrinogen receptor antagonists claimed by DuPont Merck

May 22, 1998

U.S. market introduction announced for Plavix

May 22, 1998

DuPont Merck presents new anticoagulants

May 21, 1998

Selective thrombin inhibitors described by Merck scientists

May 20, 1998

Cor's fibrinogen antagonist on the way to market

May 19, 1998

Recombinant antithrombin III pivotal clinical trials begin

May 18, 1998

Merck characterizes new orally bioavailable thrombin inhibitor: L-374087

May 18, 1998

Corvas' small-protein antithrombotic enters U.S. clinical trials

May 15, 1998

FDA issues nonapprovable letter for Novastan

May 14, 1998

YM-337 shows therapeutic potential for the treatment of coronary thrombosis

May 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...